Silence Therapeutics launches $150M ADS offering
What's the deal? Silence TherapeuticsDealroom has a profile for this one. Try Dealroom → (SLN:NASDAQ) has launched an underwritten public offering of about $150 million of its American Depositary Shares (ADSs) in the United States. Each ADS represents three ordinary shares.
The details: The company also intends to grant underwriters an option to purchase additional ADSs. The capital is being raised through a post-IPO equity offering.
Why it matters: The $150 million offering is among the larger post-IPO equity offerings by a company in its sector and region over the past 48 months, according to the article's analysis.
Read more: Seeking Alpha
Image credit: Generated with Gemini
